Who owns Progenics Pharmaceuticals?

Key details on Progenics Pharmaceuticals (Ticker: PGNX)

Who owns Progenics Pharmaceuticals?

Is PGNX a good stock to own? Find out who bought Progenics Pharmaceuticals, who sold Progenics Pharmaceuticals (PGNX) stock, and who holds a large position in Progenics Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Federated Investors 13.51M $70.11M Sept. 30, 2014
Broadfin Capital 6.64M $28.60M June 30, 2014
FMR 5.04M $26.18M Sept. 30, 2014
Baker Bros. Advisors 4.45M $23.09M Sept. 30, 2014
BlackRock Fund Advisors 2.52M $13.06M Sept. 30, 2014
Tudor Investment Corporation 2.36M $12.23M Sept. 30, 2014
BlackRock Institutional Trust Company, N.A. 2.34M $12.13M Sept. 30, 2014
Vanguard 2.06M $10.70M Sept. 30, 2014
Highland Capital Management 1.59M $8.25M Sept. 30, 2014
Wellington Management Company 1.57M $6.76M June 30, 2014
Tiger Management 1.29M $6.70M Sept. 30, 2014
Phocas Financial 1.09M $5.66M Sept. 30, 2014
Deerfield Management Company 1.04M $5.60M March 31, 2013
STATE STREET CORPORATION 999192 $5.19M Sept. 30, 2014
MORGAN STANLEY 814948 $4.23M Sept. 30, 2014
Franklin Resources 786716 $3.51M June 30, 2013
Taconic Capital Advisors 785982 $3.21M March 31, 2014
NORTHERN TRUST 743629 $3.85M Sept. 30, 2014
DIMENSIONAL FUND ADVISORS 708064 $2.90M March 31, 2014

Who sold Progenics Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Perceptive Advisors Dec. 31, 2010 1.17M $6.38M